Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
State Key Laboratory of Cardiovascular Disease, Department of Vascular Surgery, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.
Catheter Cardiovasc Interv. 2024 Nov;104(5):990-998. doi: 10.1002/ccd.31235. Epub 2024 Sep 18.
Coronary Artery Fistulas (CAFs) Patients with aneurysm may face severe complications, necessitating prompt treatment. However, data on the outcomes of transcatheter closure in CAFs patients with aneurysm are notably scarce.
This retrospective study included all consecutive CAFs patients who underwent transcatheter closure at Fuwai Hospital from January 2010 to December 2023. Patients were divided into two groups based on the presence of aneurysm, and baseline characteristics, anatomical features, and transcatheter closure outcomes were further compared.
The study ultimately included 104 patients, consisting of 56 in the aneurysm group and 48 in the non-aneurysm group. Patients in the aneurysm group were younger [39.79 (16.35) versus 50.69 (13.31) years, p < 0.001] and more frequently present with heart murmurs (21.43% vs. 6.25%, p = 0.03). Multivariate logistic regression indicated that a larger fistula diameter and the presence of CCFs are independent risk factors for the presence of aneurysm in CAF patients. The procedural success rate (75% vs. 75%, P = 1), fistula recanalization rate (11.11% vs. 16.67%, p = 0.42), and reintervention rate (3.7% vs. 6.25%, p = 0.89) were similar between the aneurysm and non-aneurysm groups.
A larger fistula diameters and the presence of coronary-cameral fistulas are independent risk factors for the occurrence of aneurysms in patients with CAFs. The outcomes of transcatheter closure are comparable for CAFs patients with and without aneurysm, though post-closure thrombosis within the fistula appears to be more common in patients with aneurysm.
冠状动脉瘘(CAF)合并动脉瘤的患者可能面临严重并发症,需要及时治疗。然而,关于 CAF 合并动脉瘤患者经导管封堵治疗结局的数据却非常有限。
本回顾性研究纳入了 2010 年 1 月至 2023 年 12 月在阜外医院接受经导管封堵治疗的所有连续 CAF 患者。根据是否存在动脉瘤将患者分为两组,进一步比较两组的基线特征、解剖特征和经导管封堵治疗结局。
本研究最终纳入 104 例患者,其中动脉瘤组 56 例,无动脉瘤组 48 例。动脉瘤组患者更年轻[39.79(16.35)岁比 50.69(13.31)岁,p<0.001],更常出现心脏杂音(21.43%比 6.25%,p=0.03)。多因素 logistic 回归分析表明,瘘口直径较大和存在冠状静脉-心腔瘘是 CAF 患者合并动脉瘤的独立危险因素。两组间手术成功率(75%比 75%,P=1)、瘘口再通率(11.11%比 16.67%,p=0.42)和再次介入治疗率(3.7%比 6.25%,p=0.89)相似。
瘘口直径较大和存在冠状静脉-心腔瘘是 CAF 患者发生动脉瘤的独立危险因素。CAF 合并与不合并动脉瘤患者的经导管封堵治疗结局相似,但动脉瘤患者的瘘口内血栓形成似乎更为常见。